Predicting long-term mortality after first coronary revascularization-The kyoto model-

Circulation Journal

Volumn 76, Issue 2, 2012, Pages 328-334

  Tanaka, Shiro ^a   Sakata, Ryuzo ^b   Marui, Akira ^a,b   Furukawa, Yutaka ^c   Kita, Toru ^c   Kimura, Takeshi ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Coronary artery bypass grafting; Percutaneous coronary intervention (PCI); Risk factors

Indexed keywords

AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; KYOTO MODEL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS;

EID: 84856266738     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0398     Document Type: Article

References (35)

1. O'Connor GT, Malenka DJ, Quinton H, Robb JF, Kellett MA Jr, Shubrooks S, et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996: Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 1999; 34: 681-691.
2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842.
3. Moscucci M, Kline-Rogers E, Share D, O'Donnell M, Maxwell-Eward A, Meengs WL, et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation 2001; 104: 263-268.
4. Resnic FS, Ohno-Machado L, Selwyn A, Simon DI, Popma JJ. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol 2001; 88: 5-9.
5. Resnic FS, Ohno-Machado L, Selwyn A, Simon DI, Popma JJ. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. J Am Coll Cardiol 2002; 39: 1104-1112.
6. Holmes DR, Selzer F, Johnston JM, Kelsey SF, Holubkov R, Cohen HA, et al; National Heart, Lung, and Blood Institute Dynamic Registry. Modeling and risk prediction in the current era of interventional cardiology: A report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation 2003; 107: 1871-1876.
7. Singh M, Lennon RJ, Holmes DR Jr, Bell MR, Rihal CS. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002; 40: 387-393.
8. Qureshi MA, Safian RD, Grines CL, Goldstein JA, Westveer DC, Glazier S, et al. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol 2003; 42: 1890-1895.
9. Constantinides SS, Osman F, Chit A, Halim M, Been M, Singh H, et al. A simple risk score for prediction of mortality in patients undergoing percutaneous coronary intervention (PCI) for non-ST segment elevation acute coronary syndromes (NSTEACS). EuroIntervention 2007; 2: 493-499.
10. Chowdhary S, Ivanov J, Mackie K, Seidelin PH, Dzavík V. The Toronto score for in-hospital mortality after percutaneous coronary interventions. Am Heart J 2009; 157: 156-163.
11. Hamburger JN, Walsh SJ, Khurana R, Ding L, Gao M, Humphries KH, et al. Percutaneous coronary intervention and 30-day mortality: The British Columbia PCI risk score. Catheter Cardiovasc Interv 2009; 74: 377-385.
12. Brener SJ, Colombo KD, Haq SA, Bose S, Sacchi TJ. Precision and accuracy of risk scores for in-hospital death after percutaneous coronary intervention in the current era. Catheter Cardiovasc Interv 2010; 75: 153-157.
13. Ergelen M, Gorgulu S, Uyarel H, Norgaz T, Ayhan E, Akkaya E, et al. Prediction of cardiovascular mortality in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention. Coron Artery Dis 2010; 21: 207-211.
14. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score. J Am Coll Cardiol 2005; 45: 1397-1405.
15. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE). BMJ 2006; 333: 1091.
16. Mehta RH, O'Neill WW, Harjai KJ, Cox DA, Brodie BR, Boura J, et al; Primary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. Am J Cardiol 2006; 97: 817-822.
17. Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, et al; CREDO-Kyoto Investigators. Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization. Circ J 2009; 73: 1459-1465.
18. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
19. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88: S2-S22.
20. Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: A systematic review of international performance. Eur J Cardiothorac Surg 2004; 25: 695-700.
21. Motomura N, Miyata H, Tsukihara H, Okada M, Takamoto S; Japan Cardiovascular Surgery Database Organization. First report on 30-day and operative mortality in risk model of isolated coronary artery bypass grafting in Japan. Ann Thorac Surg 2008; 86: 1866-1872.
22. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118: S199-S209.
23. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: S5-S20.
24. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
25. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003; 24: 881-882.
26. Wang ZJ, Zhou YJ, Liu YY, Shi DM, Zhao YX, Guo YH, et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J 2009; 73: 1228-1234.
27. Yamagata K, Kataoka Y, Kokubu N, Kasahara Y, Abe M, Nakajima H, et al. A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 2010; 74: 671-678.
28. Shimizu T, Ohno T, Ando J, Fujita H, Nagai R, Motomura N, et al. Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease. Circ J 2010; 74: 449-455.
29. Singh M, Rihal CS, Lennon RJ, Garratt KN, Holmes DR Jr. A critical appraisal of current models of risk stratification for percutaneous coronary interventions. Am Heart J 2005; 149: 753-760.
30. Dohi T, Miyauchi K, Kasai T, Kajimoto K, Kubota N, Tamura H, et al. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome. Circ J 2009; 73: 1454-1458.
31. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-1197.
32. Nishimi M, Tashiro T. Off-pump coronary artery bypass vs percutaneous coronary intervention: Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI (OPCAB-side). Circ J 2010; 74: 2750-2757.
33. Takayama T, Hiro T, Hirayama A. Is angioplasty able to become the gold standard of treatment beyond bypass surgery for patients with multivessel coronary artery disease?: Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI (PCI-side). Circ J 2010; 74: 2744-2749.
34. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
35. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, et al. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009; 54: 894-902.